WallStSmart
CELU

Celularity Inc

NASDAQ: CELU · HEALTHCARE · BIOTECHNOLOGY

$0.93
-2.68% today

Updated 2026-04-30

Market cap
$32.01M
P/E ratio
P/S ratio
0.79x
EPS (TTM)
$-3.33
Dividend yield
52W range
$1 – $4
Volume
0.2M

WallStSmart proprietary scores

19
out of 100
Grade: F
Strong Sell
Investment rating
4.7
Growth
C
5.0
Quality
C+
2.0
Profitability
F
6.7
Valuation
B
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$2.50
+167.58%
12-Month target
Intrinsic (DCF)
$9.22
Margin of safety
+86.66%

Price chart

X-Ray snapshot

Strengths
+ 86.66% below intrinsic value
Risks
- Thin margins at -198.80%
- Negative free cash flow $-4.21M
- Revenue declining -43.20% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2021202220232024TTM
Revenue$21.34M$17.98M$22.77M$54.22M$40.58M
Net income$-100.12M$14.19M$-196.29M$-57.89M$-23.07M
EPS$-3.33
Free cash flow$-116.30M$-143.11M$-42.73M$-6.56M$-4.21M
Profit margin-469.27%78.95%-862.04%-106.77%-198.80%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
CELU$32.01M194.72.06.75.0+86.66%Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Celularity Inc trades at $0.93. Our Smart Value Score of 19/100 indicates the stock is weak. TTM revenue stands at $40.58M. with profit margins at -198.80%. Our DCF model estimates intrinsic value at $9.22.

Frequently asked questions

What is Celularity Inc's stock price?
Celularity Inc (CELU) trades at $0.93.
Is Celularity Inc overvalued?
Smart Value Score 19/100 (Grade F, Strong Sell). DCF value $9.22.
What is the price target of Celularity Inc (CELU)?
The analyst target price is $2.50, representing +167.6% upside from the current price of $0.93.
What is the intrinsic value of Celularity Inc (CELU)?
Based on our DCF model, intrinsic value is $9.22, a +86.7% margin of safety versus $0.93.
What is Celularity Inc's revenue?
TTM revenue is $40.58M.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio0.79x
ROE-6,367.00%
Beta0.71
50D MA$1.27
200D MA$1.90
Shares out0.03B
Float0.02B
Short ratio
Avg volume0.2M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years